Literature DB >> 920716

Surgical management of toxic megacolon.

G Roys, M S Kaplan, G L Juler.   

Abstract

Toxic megacolon developed in ten of 220 patients (4.5%) admitted for chronic ulcerative colitis over the past 11 years. Nine of these patients came under the care of the Surgical Department. Only three of these 10 patients had previously been treated with steroids. Steroid therapy reversed the acute process in three patients (33%). All three patients later came to surgery. Toxic megacolon developed during the first episode of ulcerative colitis in seven of ten patients (70%). Three of the seven (43%) had perforated their colons prior to operation. Two patients died after a subtotal colectomy and one without operation. A delayed diagnosis was associated with sepsis in five patients (50%) and with all three deaths. Seven patients survived proctocolectomy. Prolonged medical management without dramatic response appeared to correlate with a high postoperative morbidity. This study supports the concept of aggressive diagnosis and early surgical intervention for toxic megacolon.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 920716

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  3 in total

1.  Incidence, features, in-hospital outcomes and predictors of in-hospital mortality associated with toxic megacolon hospitalizations in the United States.

Authors:  Rajkumar Doshi; Jiten Desai; Yash Shah; Dean Decter; Shreyans Doshi
Journal:  Intern Emerg Med       Date:  2018-06-12       Impact factor: 3.397

Review 2.  Colectomy in patients with acute colitis: a systematic review.

Authors:  P H E Teeuwen; M W J Stommel; A J A Bremers; G J van der Wilt; D J de Jong; R P Bleichrodt
Journal:  J Gastrointest Surg       Date:  2009-01-09       Impact factor: 3.452

Review 3.  Toxic Megacolon: Background, Pathophysiology, Management Challenges and Solutions.

Authors:  Jiten Desai; Mohamed Elnaggar; Ahmed A Hanfy; Rajkumar Doshi
Journal:  Clin Exp Gastroenterol       Date:  2020-05-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.